Cargando…
Exercise Capacity Is Improved by Levosimendan in Heart Failure and Sarcopenia via Alleviation of Apoptosis of Skeletal Muscle
BACKGROUND: Patients suffering from chronic heart failure (CHF) show an increased prevalence of sarcopenia. Levosimendan is an effective drug for the treatment of heart failure, but its effect on sarcopenia is still unclear. We aimed to explore whether levosimendan could enhance skeletal muscle cont...
Autores principales: | Wang, Di, Song, Ming, Shen, Long-fei, Han, Lu, Zhu, Ping, Jia, Xu, Shang, Guo-kai, Cao, Yuan, Zhang, Wei, Zhong, Ming, Wang, Zhi-hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811365/ https://www.ncbi.nlm.nih.gov/pubmed/35126176 http://dx.doi.org/10.3389/fphys.2021.786895 |
Ejemplares similares
-
Intracoronary Levosimendan during Ischemia Prevents Myocardial Apoptosis
por: Malmberg, Markus, et al.
Publicado: (2012) -
Advances in exercise to alleviate sarcopenia in older adults by improving mitochondrial dysfunction
por: Zhu, Yang, et al.
Publicado: (2023) -
Endoplasmic reticulum stress in human skeletal muscle: any contribution to sarcopenia?
por: Deldicque, Louise
Publicado: (2013) -
Exercise and Dietary-Protein as a Countermeasure to Skeletal Muscle Weakness: Liverpool Hope University – Sarcopenia Aging Trial (LHU-SAT)
por: Kirk, Ben, et al.
Publicado: (2019) -
Elevated Nicotinamide Phosphoribosyl Transferase in Skeletal Muscle Augments Exercise Performance and Mitochondrial Respiratory Capacity Following Exercise Training
por: Brouwers, Bram, et al.
Publicado: (2018)